Researchers from Rice University and Vanderbilt University have made significant advancements in the fight against prostate ...

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...

An analysis of prostate cancer trends in California revealed an unexpected spike in distant-stage disease cases between 2011 and 2021.Meanwhile, prostate cancer mortality — which had been on the ...

A new report shows while cancer death rates among Black people are declining, they remain higher than other racial and ethnic groups.

The new 3D tissue analysis of thyroid tumors is still unfamiliar to pathologists. Instead of cutting the removed tissue into thin slices and viewing them two-dimensionally under the microscope as ...

A 96-week clinical trial found that 300 mg of Vitamin E significantly improved liver histology and reduced inflammation in ...

Melbourne-based scientists have, for the first time, discovered how to "switch off" a molecule which is one of the top ...

A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.

Based on work Dr. Petrylak presented at ASCO 2024 looking at dose adjustment and efficacy of enfortumab vedotin, most ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

(UroToday.com) The 2025 GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Ivan de Kouchkovsky discussing the impact of baseline PSMA PET in patients with metastatic ...

There are differences in prostate cancer treatment intensification adoption between academic and nonacademic physicians.